These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32609820)

  • 61. Single molecule methods for studying CRISPR Cas9-induced DNA unwinding.
    Okafor IC; Choi J; Ha T
    Methods; 2022 Aug; 204():319-326. PubMed ID: 34767923
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interrogation of the dynamic properties of higher-order heterochromatin using CRISPR-dCas9.
    Gao Y; Han M; Shang S; Wang H; Qi LS
    Mol Cell; 2021 Oct; 81(20):4287-4299.e5. PubMed ID: 34428454
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
    Fu Y; Sander JD; Reyon D; Cascio VM; Joung JK
    Nat Biotechnol; 2014 Mar; 32(3):279-284. PubMed ID: 24463574
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Logical regulation of endogenous gene expression using programmable, multi-input processing CRISPR guide RNAs.
    Kang H; Park D; Kim J
    Nucleic Acids Res; 2024 Aug; 52(14):8595-8608. PubMed ID: 38943344
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins.
    Yu L; Zhang Y; Marchisio MA
    J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342156
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tunable Repression of Key Photosynthetic Processes Using Cas12a CRISPR Interference in the Fast-Growing Cyanobacterium
    Knoot CJ; Biswas S; Pakrasi HB
    ACS Synth Biol; 2020 Jan; 9(1):132-143. PubMed ID: 31829621
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
    Chaudhary K; Chattopadhyay A; Pratap D
    J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs.
    Maxwell CS; Jacobsen T; Marshall R; Noireaux V; Beisel CL
    Methods; 2018 Jul; 143():48-57. PubMed ID: 29486239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Building Endogenous Gene Connections through RNA Self-Assembly Controlled CRISPR/Cas9 Function.
    Lin J; Wang WJ; Wang Y; Liu Y; Xu L
    J Am Chem Soc; 2021 Dec; 143(47):19834-19843. PubMed ID: 34788038
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
    Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tuning the Expression of Long Noncoding RNA Loci with CRISPR Interference.
    Stojic L
    Methods Mol Biol; 2020; 2161():1-16. PubMed ID: 32681501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
    Suresh B; Ramakrishna S; Kim H
    Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.
    Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA
    Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3.
    Carabias A; Fuglsang A; Temperini P; Pape T; Sofos N; Stella S; Erlendsson S; Montoya G
    Nat Commun; 2021 Jul; 12(1):4476. PubMed ID: 34294706
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CRISPR-Cas-Mediated Chemical Control of Transcriptional Dynamics in Yeast.
    Cunningham-Bryant D; Sun J; Fernandez B; Zalatan JG
    Chembiochem; 2019 Jun; 20(12):1519-1523. PubMed ID: 30710419
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9-Cas12a platform.
    Gonatopoulos-Pournatzis T; Aregger M; Brown KR; Farhangmehr S; Braunschweig U; Ward HN; Ha KCH; Weiss A; Billmann M; Durbic T; Myers CL; Blencowe BJ; Moffat J
    Nat Biotechnol; 2020 May; 38(5):638-648. PubMed ID: 32249828
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila.
    Gratz SJ; Ukken FP; Rubinstein CD; Thiede G; Donohue LK; Cummings AM; O'Connor-Giles KM
    Genetics; 2014 Apr; 196(4):961-71. PubMed ID: 24478335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.